As of 3:29:01 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,356.0000
--
--
--
Operating Expense
18,594.0000
22,510.0000
17,589.0000
13,832.0000
Operating Income
-15,238.0000
-22,510.0000
-17,589.0000
-13,832.0000
Net Non Operating Interest Income Expense
-5,013.0000
-8,230.0000
-210.0000
-60.0000
Pretax Income
-20,252.0000
-30,740.0000
-17,799.0000
-13,893.0000
Tax Provision
-2,725.0000
-4,213.0000
-3,143.0000
-2,324.0000
Net Income Common Stockholders
-17,527.0000
-26,527.0000
-14,656.0000
-11,569.0000
Diluted NI Available to Com Stockholders
-17,527.0000
-26,527.0000
-14,656.0000
-11,569.0000
Basic EPS
-1.16
-1.92
-2.06
-3.09
Diluted EPS
-1.16
-1.92
-2.06
-3.09
Basic Average Shares
16,438.9970
13,788.7550
7,100.5070
6,112.5350
Diluted Average Shares
16,438.9970
13,788.7550
7,100.5070
6,112.5350
Total Expenses
18,594.0000
22,510.0000
17,589.0000
13,832.0000
Net Income from Continuing & Discontinued Operation
-17,527.0000
-26,527.0000
-14,656.0000
-11,569.0000
Normalized Income
-17,527.0000
-26,527.0000
-14,656.0000
-11,569.0000
Interest Expense
--
8,230.0000
210.0000
60.0000
Net Interest Income
-5,013.0000
-8,230.0000
-210.0000
-60.0000
EBIT
-15,239.0000
-22,510.0000
-17,589.0000
-13,833.0000
EBITDA
-15,239.0000
-22,510.0000
-17,589.0000
-13,833.0000
Net Income from Continuing Operation Net Minority Interest
-17,527.0000
-26,527.0000
-14,656.0000
-11,569.0000
Normalized EBITDA
-15,239.0000
-22,510.0000
-17,589.0000
-13,833.0000
Tax Rate for Calcs
0.0001
0.0001
0.0002
0.0002
12/31/2021 - 5/6/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1S9.F Seres Therapeutics, Inc.
0.8196
-0.49%
J90.F NurExone Biologic Inc.
0.5200
-3.70%
VLA.VI Valneva SE
1.7510
-5.30%
BBZA.DE BB Biotech AG Ord
38.25
-0.13%
FRX.TO Fennec Pharmaceuticals Inc.
8.68
0.00%
TGRP TRON Group Inc.
0.0420
-13.40%
296.SG CytoDyn Inc
0.1270
+9.48%
NRSNW NeuroSense Therapeutics Ltd.
0.3000
+20.00%
FYB.DE Formycon AG
53.60
+1.52%
CLVLY Clinuvel Pharmaceuticals Limited
7.91
+1.02%